Pharmaceuticals & Biotechnology | Pharma & Biotech Resources

On behalf of Legal IQ, Jim Vint, Managing Director at Navigant, interviews Patrick Oot, Co-Founder and GC, Electronic Discovery Institute, Special Counsel, Electronic Discovery at US Securities and Exchange Commission about the latest developments in Information Governance.   Have

On behalf of Legal IQ, Jim Vint, Managing Director at Navigant, interviews Patrick Oot, Co-Founder and GC, Electronic Discovery Institute, Special Counsel, Electronic Discovery at US Securities and Exchange Commission about the latest developments in Information Governance.   Have

Joshua Holzer, Chief Compliance Counsel for Global Trade, Pfizer Inc, joins Pharma IQ to discuss common concerns of pharma companies when it comes to compliance regulatory investigations and strategies that in house counsel can use to help their company protect itself and better manage

Joshua Holzer, Chief Compliance Counsel for Global Trade, Pfizer Inc, joins Pharma IQ to discuss common concerns of pharma companies when it comes to compliance regulatory investigations and strategies that in house counsel can use to help their company protect itself and better manage

The distribution of clinical supplies can be a challenge for any trial. Paul Wiberg-Jørgensen, Vice President, Logistics, Statens Serum Institute, joins Andrea Charles from Pharma IQ, to discuss w hat steps the SSI is taking to overcome the challenges of clinical trial supply

The distribution of clinical supplies can be a challenge for any trial. Paul Wiberg-Jørgensen, Vice President, Logistics, Statens Serum Institute, joins Andrea Charles from Pharma IQ, to discuss w hat steps the SSI is taking to overcome the challenges of clinical trial supply

Eli Lilly's experience of complying with strict Turkish serialisation requirements has taught them how to handle future implementation of serialisation globally in a more effective manner, explains Hicham Safine, Europe/AMEA/CIS Quality Consultant at Eli Lilly. And just how will the

Solving solubility problems is one of the leading challenges in drug development, as poorly soluble compounds are estimated to account for 60% of compounds. Preclinical development encompasses the activities that link the drug discovery process in the lab to initiation of human clinical

Improving the solubility of new chemical entities has proven to be one of the biggest hurdles to overcome in pharmaceutical drug development, and companies are always looking for new strategies for increasing bioavailability of new drugs. Many companies are working to leverage new

With several thousand clinical trials currently running in Scandinavia, Nordic biotech and pharma companies, CROs and research institutions are increasingly extending their reach into other geographic regions. In this candid interview, Maria Ohlander, Head of

Disposables (Single-Use) systems have been widely established in pharmaceutical and biotechnology companies’ biomanufacturing processes across Europe and the US with proven economic and fast product changeover benefits. Recently, suppliers are

Up to 50% of patients may not be taking their medication as prescribed. Tassilo Korab, Executive Director for the European Healthcare Packaging Compliance Council explains how the Pharmaceutical Industry can optimise packaging and labelling to increase chronic patient

Purchasing new software is a significant commercial and resource investment for any level of the pharmaceutical industry. Smooth implementation is essential to minimizing the impact it will have on the organization and internal processes. In this podcast, Prasad Panzade, Director of

Informatics has been an important catalyst for globalisation, but how is globalisation impacting laboratory informatics? In this interview Eduard de Vries, Senior Manager IT Reference Laboratories & Asia-Pacific from  IDEXX Laboratories and Andrea Charles from Pharma IQ,

China is now the world’s third-largest pharmaceutical market. In this interview Stefano Accorsi, Director, International Regulatory Affairs, International Comercial Operations, Chiesi Farmaceutici S.p.A, speaks to Andrea Charles from Pharma IQ, about the changes he has